CEL-SCI CORPORATION Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest
CEL-SCI CORPORATION (CVM) reported Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest of -$23.65 million for the 12-month period ending 2016-09-30, per its 10-K/A filed 2017-12-11.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest · last filed 2017-12-11
- CEL-SCI CORPORATION income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2016 was -$23.65M.
- CEL-SCI CORPORATION income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2015 was -$32.39M.
- CEL-SCI CORPORATION income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2014 was -$25.67M.
| Period end | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|
| 2016-09-30 | -$23.65M 10-K/A · filed 2017-12-11 |
| 2015-09-30 | -$32.39M 10-K/A · filed 2017-12-11 |
| 2014-09-30 | -$25.67M 10-K/A · filed 2017-12-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |